Revelation Biosciences, Inc.
REVB
$2.76
$0.18267.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.66% | -43.00% | -0.64% | -45.82% | -17.03% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.70% | 234.78% | -43.38% | -6.28% | 74.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 36.46% | -40.18% | -1.40% | -45.41% | -16.58% |
|
|
|||||
| Total Current Assets | 36.46% | -40.18% | -1.40% | -45.41% | -16.58% |
| Net Property, Plant & Equipment | -16.98% | -24.69% | -30.67% | 14.69% | -9.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 35.89% | -40.04% | -1.75% | -45.07% | -16.54% |
|
|
|||||
| Total Accounts Payable | 32.60% | -20.23% | -74.94% | 144.07% | -23.81% |
| Total Accrued Expenses | 59.53% | -58.89% | 20.70% | -88.95% | 1,262.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | -63.64% | -54.17% | -99.66% | -52.38% |
| Total Other Current Liabilities | 0.00% | -63.64% | -54.17% | -99.66% | -52.38% |
| Total Current Liabilities | 44.04% | -43.07% | -52.94% | -63.46% | 112.86% |
|
|
|||||
| Total Current Liabilities | 44.04% | -43.07% | -52.94% | -63.46% | 112.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 44.04% | -43.07% | -52.94% | -63.46% | 112.86% |
|
|
|||||
| Common Stock & APIC | 7.46% | 0.49% | 9.07% | 10.02% | 0.15% |
| Retained Earnings | -5.74% | -5.06% | -4.45% | -6.13% | -29.81% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 32.80% | -38.82% | 76.11% | 134.44% | -87.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.80% | -38.82% | 76.11% | 134.44% | -87.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.80% | -38.82% | 76.11% | 134.44% | -87.96% |
|
|
|||||